NCT01187199 2026-04-16
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
Clinical Trials
156 trialsNCT02911064 2026-04-16
Expectations Regarding Mobility and Self-Care
M.D. Anderson Cancer Center
Active not recruiting
NCT05836857 2026-04-16
The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study
M.D. Anderson Cancer Center
Active not recruiting
NCT02337452 2026-04-15
Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
M.D. Anderson Cancer Center
Active not recruiting
NCT02387905 2026-04-15
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03671226 2026-04-15
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04957615 2026-04-15
Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05347212 2026-04-15
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03768336 2026-04-14
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
Massachusetts General Hospital
Phase NA Active not recruiting
NCT04520711 2026-04-13
Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
Providence Health & Services
Phase 1 Active not recruiting
NCT01706939 2026-04-09
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Icahn School of Medicine at Mount Sinai
Phase 3 Active not recruiting
NCT05479708 2026-04-08
ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma
Ruijin Hospital
Active not recruiting
NCT06745024 2026-04-08
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
NRG Oncology
Phase 3 Active not recruiting
NCT06939452 2026-04-07
A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression
The First Affiliated Hospital of Zhengzhou University
Phase 2 Active not recruiting
NCT05784766 2026-04-06
SARIC
University of Oklahoma
Phase NA Active not recruiting
NCT04713046 2026-04-02
Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Active not recruiting
NCT06926972 2026-04-01
NOURISH
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Active not recruiting
NCT07321392 2026-03-31
Psychometric Validation of the Psychosocial Assessment Tool in Caregivers of Pediatric Cancer Patients.
Aquà Nadie Se Rinde I.A.P.
Active not recruiting
NCT04050072 2026-03-30
Patient-Reported Outcome Version of the Common Criteria for Adverse Events
St. Jude Children's Research Hospital
Active not recruiting
NCT03809377 2026-03-27
Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)
Institute of Cancer Research, United Kingdom
Active not recruiting
NCT04538482 2026-03-27
DINING
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Active not recruiting
NCT07474168 2026-03-16
T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
Zhejiang University
Phase 1 Active not recruiting
NCT04318886 2026-03-13
Lay Coach-Led Early Palliative Care for Underserved Advanced Cancer Caregivers: The Project ENABLE Cornerstone RCT
University of Alabama at Birmingham
Phase 3 Active not recruiting
NCT04803604 2026-03-12
CASCADE
University of Alabama at Birmingham
Phase NA Active not recruiting
NCT07468422 2026-03-12
OPTin
China Medical University Hospital
Active not recruiting
NCT05763797 2026-03-11
Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06864260 2026-03-11
PREEMpT
University of Alabama at Birmingham
Phase NA Active not recruiting
NCT05707910 2026-03-09
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
West China Hospital
Phase 1 Active not recruiting
NCT06549153 2026-03-09
ACT-Together (Acting on Cancer Testing-Together)
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT01428895 2026-03-06
Femoral Bone Metastases
University Health Network, Toronto
Phase NA Active not recruiting
NCT04135794 2026-03-05
MRL1
University Health Network, Toronto
Active not recruiting
NCT00832325 2026-03-03
Adolescent and Young Adult Cancer Survivors: Identity Development
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT04913259 2026-03-03
TS-PAC
Institut Bergonié
Phase NA Active not recruiting
NCT07411105 2026-02-27
CORreCT
Our Lady's Hospice and Care Services
Active not recruiting
NCT02830451 2026-02-25
MTRON
AO Innovation Translation Center
Active not recruiting
NCT03203525 2026-02-25
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT05823740 2026-02-20
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
UNC Lineberger Comprehensive Cancer Center
Phase NA Active not recruiting
NCT03927885 2026-02-19
Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT04150900 2026-02-19
1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
University of Maryland, Baltimore
Phase 2 Active not recruiting
NCT06754501 2026-02-18
A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07093567 2026-02-18
Opiophobia in Adults With Advanced Cancer
M.D. Anderson Cancer Center
Active not recruiting
NCT04150939 2026-02-17
Cryoablation for the Treatment of Metastatic Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05117931 2026-02-17
A Study of Amivantamab in People With Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06340906 2026-02-13
Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
University of California, Irvine
Phase NA Active not recruiting
NCT07396740 2026-02-09
DISTRO
University Hospital, Brest
Active not recruiting
NCT04733469 2026-02-02
EMPOWER 3
Tulane University
Phase NA Active not recruiting
NCT03436290 2026-01-28
SCOPE
Vanderbilt University Medical Center
Phase NA Active not recruiting
NCT06693128 2026-01-28
Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer
Ruijin Hospital
Phase 2 Active not recruiting
NCT07368192 2026-01-26
Community-Based Exercise Oncology: Real-World Evidence of High Adherence, Improved Quality of Life and Cost-Effectiveness Across the Cancer Continuum
University of Castilla-La Mancha
Active not recruiting
NCT04208347 2026-01-23
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer
Ruijin Hospital
Phase 2/3 Active not recruiting